http://www.prescriber.co.uk/article/can-drug-price-hikes-via-debranding-prevented/
http://www.telegraph.co.uk/news/2017/01/28/cancer-patients-lose-drug-price-hikes-1000/
- and the US experience is that patients are being gouged even when there is "competition":
http://www.latimes.com/business/la-fi-mylan-price-hikes-20160830-snap-story.html
For how this affects English patients in practice, listen to one pharmacist's experience on the latest "Inside Health". I have no reason to believe that it is any different in Wales.
No comments:
Post a Comment